Back to Search
RICHARD SHELTON, M.D.
M.D.
Internal Medicine Physician
NPI: 1326069626Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
23249(KY)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
3
With Results
Medication, Weight Gain and GI Hormones
NCT00384332COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
NCT00571688COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
NCT01134731COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression.
PMID 21808751·Ann Clin Psychiatry·2011
4-observational
Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients.
PMID 15737248·Int J Neuropsychopharmacol·2005
3-trial
Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism.
PMID 15765795·Essent Psychopharmacol·2005
6-review
Diabetes mellitus during olanzapine and quetiapine treatment in Japan.
PMID 15705015·J Clin Psychiatry·2005
5-case
Stable monotherapy with clozapine or olanzapine increases the incidence of diabetes mellitus in people with schizophrenia.
PMID 15671515·Evid Based Ment Health·2005
8-other
Weight gain and new onset diabetes associated with olanzapine and risperidone.
PMID 15610330·J Gen Intern Med·2004
4-observational
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
PMID 14609883·Arch Gen Psychiatry·2003
3-trial
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
PMID 12629531·Neuropsychopharmacology·2003
4-observational
Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.
PMID 19573263·Int J Neuropsychopharmacol·2009
8-other
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.
PMID 19590732·Neuropsychiatr Dis Treat·2009
8-other
Localized delivery of growth factors for periodontal tissue regeneration: role, strategies, and perspectives.
PMID 19260070·Med Res Rev·2009
6-review
A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men.
PMID 19477736·Am J Mens Health·2009
8-other
Early adverse events, HPA activity and rostral anterior cingulate volume in MDD.
PMID 19325704·PLoS One·2009
8-other
Multivitamin use among multi-ethnic, low-income adults.
PMID 19412739·Cancer Causes Control·2009
8-other
An alginate hydrogel matrix for the localised delivery of a fibroblast/keratinocyte co-culture.
PMID 19452469·Biotechnol J·2009
7-preclinical
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
PMID 19282313·Heart·2009
4-observational
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.
PMID 19634969·J Consult Clin Psychol·2009
4-observational
Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.
PMID 19640209·Expert Opin Pharmacother·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 801 EASTERN BYP
RICHMOND, KY 40475 - Phone
- (859) 625-3836
Quick Facts
- NPI
- 1326069626
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile